Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $49.35 ($1.1M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $1.1M HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.35 | 9,010 | $445K | 41.8% |
| 2 | $49.35 | 9,010 | $445K | 41.8% |
| 3 | $49.91 | 1,740 | $87K | 8.2% |
| 4 | $49.91 | 1,740 | $87K | 8.2% |
| Total | $49.44 avg | 21,500 | $1.1M | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |